{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:20:39Z","timestamp":1791836439857,"version":"4.3.4"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Boromycin is a boron-containing macrolide antibiotic produced by <jats:italic>Streptomyces antibioticus<\/jats:italic> with potent activity against certain viruses, Gram-positive bacteria and protozoan parasites. Most antimalarial antibiotics affect plasmodial organelles of prokaryotic origin and have a relatively slow onset of action. They are used for malaria prophylaxis and for the treatment of malaria when combined to a fast-acting drug. Despite the success of artemisinin combination therapies, the current gold standard treatment, new alternatives are constantly needed due to the ability of malaria parasites to become resistant to almost all drugs that are in heavy clinical use. <jats:italic>In vitro<\/jats:italic> antiplasmodial activity screens of tetracyclines (omadacycline, sarecycline, methacycline, demeclocycline, lymecycline, meclocycline), macrolides (oleandomycin, boromycin, josamycin, troleandomycin), and control drugs (chloroquine, clindamycin, doxycycline, minocycline, eravacycline) revealed boromycin as highly potent against <jats:italic>Plasmodium falciparum<\/jats:italic> and the zoonotic <jats:italic>Plasmodium knowlesi<\/jats:italic>. In contrast to tetracyclines, boromycin rapidly killed asexual stages of both <jats:italic>Plasmodium<\/jats:italic> species already at low concentrations (~ 1 nM) including multidrug resistant <jats:italic>P. falciparum<\/jats:italic> strains (Dd2, K1, 7G8). In addition, boromycin was active against <jats:italic>P. falciparum<\/jats:italic> stage V gametocytes at a low nanomolar range (IC<jats:sub>50<\/jats:sub>: 8.5 \u00b1 3.6 nM). Assessment of the mode of action excluded the apicoplast as the main target. Although there was an ionophoric activity on potassium channels, the effect was too low to explain the drug\u00b4s antiplasmodial activity. Boromycin is a promising antimalarial candidate with activity against multiple life cycle stages of the parasite.<\/jats:p>","DOI":"10.3389\/fcimb.2021.802294","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T05:59:47Z","timestamp":1642139987000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of Plasmodium falciparum"],"prefix":"10.3389","volume":"11","author":[{"given":"La\u00eds Pessanha","family":"de Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Groeger-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kreidenweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Mordm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e01278","DOI":"10.1128\/AAC.01278-20","article-title":"Boromycin has Potent Anti-Toxoplasma and Anti-Cryptosporidium Activity","volume":"65","author":"Abenoja","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2147\/IDR.S148664","article-title":"Plasmodium Knowlesi Malaria: Current Research Perspectives","volume":"11","author":"Amir","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of Artemisinin-Resistance Malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"NEJM"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4269\/ajtmh.1997.56.17","article-title":"Pharmacokinetics of Artemisinin and Artesunate After Oral Administration in Healthy Volunteers","volume":"56","author":"Benakis","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1128\/AAC.00527-07","article-title":"Multiple Antibiotics Exert Delayed Effects Against the Plasmodium Falciparum Apicoplast","volume":"51","author":"Dahl","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.3390\/molecules26082304","article-title":"Drug Repurposing: A Review of Old and New Antibiotics for the Treatment of Malaria: Identifying Antibiotics With a Fast Onset of Antiplasmodial Action","volume":"26","author":"de Carvalho","year":"2021","journal-title":"Molecules"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e00085","DOI":"10.1128\/AAC.00085-19","article-title":"Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium Falciparum In Vitro","volume":"63","author":"de Carvalho","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1475-2875-11-292","article-title":"A Framework for Assessing the Risk of Resistance for Anti-Malarials in Development","volume":"11","author":"Ding","year":"2012","journal-title":"Malar. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/hlca.19710540624","article-title":"Structure of Boromycin","volume":"54","author":"Dunitz","year":"1971","journal-title":"Helv. Chim. Acta"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1096\/fj.11-187401","article-title":"Identifying Apicoplast-Targeting Antimalarials Using High-Throughput Compatible Approaches","volume":"25","author":"Ekland","year":"2011","journal-title":"FASEB J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-12-425","article-title":"Susceptibility of Human Plasmodium Knowlesi Infections to Anti-Malarials","volume":"12","author":"Fatih","year":"2013","journal-title":"Malar. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-016-1114-z","article-title":"Macrolides and Associated Antibiotics Based on Similar Mechanism of Action Like Lincosamides in Malaria","volume":"15","author":"Gaillard","year":"2016","journal-title":"Malar. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12936-015-0980-0","article-title":"Tetracyclines in Malaria","volume":"14","author":"Gaillard","year":"2015","journal-title":"Malar. J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-016-1613-y","article-title":"Antibiotics in Malaria Therapy: Which Antibiotics Except Tetracyclines and Macrolides may be Used Against Malaria","volume":"556","author":"Gaillard","year":"2016","journal-title":"Malar. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3978\/j.issn.2305-5839.2015.01.23","article-title":"Plasmodium Falciparum Gametocytes: Playing Hide and Seek","volume":"3","author":"Gardiner","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"B16","first-page":"193","article-title":"The Treatment of Malaria With Tetracycline","volume":"3","author":"Grande","year":"1956","journal-title":"Antibiot. Med. Clin. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1093\/infdis\/jiz397","article-title":"Natural Human Infections With Plasmodium Cynomolgi and Other Malaria Species in an Elimination Setting in Sabah, Malaysia","volume":"220","author":"Grignard","year":"2019","journal-title":"J. Inf. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ijantimicag.2010.02.003","article-title":"In Vitro Activity of Tigecycline in Plasmodium Falciparum Culture-Adapted Strains and Clinical Isolates From Gabon","volume":"35","author":"Held","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1006\/expr.1995.1023","article-title":"Plasmodium Falciparum and Plasmodium Berghei: Effect of Magnesium on the Development of Parasitemia","volume":"80","author":"Hess","year":"1995","journal-title":"Exp. Parasitol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"20117","DOI":"10.1038\/s41598-021-99644-8","article-title":"A Comparison of the Clinical, Laboratory and Epidemiological Features of Two Divergent Subpopulations of Plasmodium Knowlesi","volume":"11","author":"Hu","year":"2021","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/hlca.19670500612","article-title":"Stoffwechselprodukte Von Mikroorganismen. 57. Mitteilung. Boromycin","volume":"50","author":"H\u00fctter","year":"1967","journal-title":"Helv. Chim. Acta"},{"key":"B22","first-page":"377","article-title":"Studies in Human Malaria. XXIX. Trials of Aureomycin, Chloramphenicol, Penicillin, and Dihydrostreptomycin Against the Chesson Strain of Plasmodium Vivax","volume":"9","author":"Imboden","year":"1950","journal-title":"J. Natl. Malar. Soc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ja.2011.6","article-title":"Borrelidin, a Potent Antimalarial: Stage-Specific Inhibition Profile of Synchronized Cultures of Plasmodium Falciparum","volume":"64","author":"Ishiyama","year":"2011","journal-title":"J. Antibiot."},{"key":"B24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/978-3-662-11266-3","volume-title":"Bor in Biologie, Medizin Und Pharmazie: Physiologische Wirkungen Und Anwendung Von Borverbindungen","author":"Klingel","year":"1980"},{"key":"B25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jgar.2020.11.024","article-title":"In Vitro Activity of Eravacycline, a Novel Synthetic Halogenated Tetracycline, Against the Malaria Parasite Plasmodium Falciparum","volume":"24","author":"Koehne","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1271\/bbb.60.1036","article-title":"Boromycin, an Anti-HIV Antibiotic","volume":"60","author":"Kohno","year":"1996","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0035019","article-title":"Activity of Clinically Relevant Antimalarial Drugs on Plasmodium Falciparum Mature Gametocytes in an ATP Bioluminescence \u201cTransmission Blocking\u201d Assay","volume":"7","author":"Leli\u00e8vre","year":"2012","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168702","article-title":"Single Dose Primaquine to Reduce Gametocyte Carriage and Plasmodium Falciparum Transmission in Cambodia: An Open-Label Randomized Trial","volume":"12","author":"Lin","year":"2017","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-017-2090-7","article-title":"Long-Term In Vitro Culture of Plasmodium Vivax Isolates From Madagascar Maintained in Saimiri Boliviensis Blood","volume":"16","author":"Mehlotra","year":"2017","journal-title":"Malar. J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02005-16","article-title":"Inhibition of Plasmodium Liver Infection by Ivermectin","volume":"61","author":"Mendes","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2014.00104","article-title":"The Systemic Pathology of Cerebral Malaria in African Children","volume":"4","author":"Milner","year":"2014","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1021\/acs.jmedchem.0c01700","article-title":"The Development of Hsp90\u03b2-Selective Inhibitors to Overcome Detriments Associated With Pan-Hsp90 Inhibition","volume":"11","author":"Mishra","year":"2021","journal-title":"J. Med. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1073\/pnas.1216457110","article-title":"Adaptation of the Genetically Tractable Malaria Pathogen Plasmodium Knowlesi to Continuous Culture in Human Erythrocytes","volume":"110","author":"Moon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00199","article-title":"Boromycin Kills Mycobacterial Persisters Without Detectable Resistance","volume":"7","author":"Moreira","year":"2016","journal-title":"Front. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/AAC.49.8.3575-3577.2005","article-title":"Simple Histidine-Rich Protein 2 Double-Site Sandwich Enzyme-Linked Immunosorbent Assay for Use in Malaria Drug Sensitivity Testing","volume":"49","author":"Noedl","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/tropicalmed4010026","article-title":"Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug","volume":"4","author":"Nsanzabana","year":"2019","journal-title":"Trop. Med. Infect. Dis."},{"key":"B37","unstructured":""},{"key":"B38","doi-asserted-by":"publisher","first-page":"727","DOI":"10.7164\/antibiotics.56.727","article-title":"In Vitro and In Vivo Antimalarial Activities of a Non-Glycosidic 18-Membered Macrolide Antibiotic, Borrelidin, Against Drug-Resistant Strains of Plasmodia","volume":"56","author":"Otoguro","year":"2003","journal-title":"J. Antibiot."},{"key":"B39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/BF00409681","article-title":"Metabolic Products of Microorganisms","volume":"67","author":"Pache","year":"1969","journal-title":"Arch. f\u00fcr. Mikrobiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF00412060","article-title":"Stoffwechselprodukte Von Mikroorganismen","volume":"288","author":"Pache","year":"1969","journal-title":"Arch. Mikrobiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of Dihydroartemisinin-Piperaquine Treatment Failure in Plasmodium Falciparum Malaria in Cambodia, Thailand, and Vietnam: A Prospective Clinical, Pharmacological, and Genetic Study","volume":"19","author":"Pluijm","year":"2019","journal-title":"Lancet Inf. Dis."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.60058","article-title":"Artemisinin Exposure at the Ring or Trophozoite Stage Impacts Plasmodium Falciparum Sexual Conversion Differently","volume":"9","author":"Portugaliza","year":"2020","journal-title":"Elife"},{"key":"B43","unstructured":"PrelogV.\n            ZaehnerH.\n            BickelH.\n          Ardsley, New YorkCiba-Geigy Corporation1973"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0066521","DOI":"10.1128\/AAC.00665-21","article-title":"In Vitro Susceptibility of Rickettsia Species to Eravacycline, Omadacycline, and Tigecycline","volume":"65","author":"Quade","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B45","volume-title":"R: A Language and Environment for Statistical Computing","year":"2014"},{"key":"B46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1371\/journal.pntd.0006230","article-title":"Use of Primaquine and Glucose-6-Phosphate Dehydrogenase Deficiency Testing: Divergent Policies and Practices in Malaria Endemic Countries","author":"Recht","year":"2018","journal-title":"PloS Negl. Trop. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-7-45","article-title":"Concentration and Purification by Magnetic Separation of the Erythrocytic Stages of All Human Plasmodium Species","volume":"7","author":"Ribaut","year":"2008","journal-title":"Malar. J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v012.i05","article-title":"Bioassay Analysis Using R","volume":"12","author":"Ritz","year":"2005","journal-title":"J. Stat. Softw."},{"key":"B49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature21038","article-title":"Plasmodium Malariae and P. Ovale Genomes Provide Insights Into Malaria Parasite Evolution","volume":"542","author":"Rutledge","year":"2017","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2015.00391","article-title":"Enlightening the Malaria Parasite Life Cycle: Bioluminescent Plasmodium in Fundamental and Applied Research","volume":"6","author":"Siciliano","year":"2015","journal-title":"Front. Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1006336","article-title":"Developing Transmission-Blocking Strategies for Malaria Control","volume":"13","author":"Sinden","year":"2017","journal-title":"PloS Pathog."},{"key":"B52","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"K13-Propeller Mutations Confer Artemisinin Resistance in Plasmodium Falciparum Clinical Isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3987\/COM-10-S(E)55","article-title":"Boromycin Derivatives: Synthesis and Antimalarial Activity In Vitro and In Vivo","volume":"82","author":"Tsutsui","year":"2010","journal-title":"Heterocycles"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e01161","DOI":"10.1128\/AAC.01161-17","article-title":"Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria","volume":"62","author":"Uddin","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B55","unstructured":"Drug Trials Snapshot: Seysara"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-34964-w","article-title":"Inducing Controlled Cell Cycle Arrest and Re-Entry During Asexual Proliferation of Plasmodium Falciparum Malaria Parasites","volume":"8","author":"van Biljon","year":"2018","journal-title":"Sci. Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpddr.2019.02.004","article-title":"Plasmodium Knowlesi Exhibits Distinct In Vitro Drug Susceptibility Profiles From Those of Plasmodium Falciparum","volume":"9","author":"van Schalkwyk","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1093\/jac\/dkx279","article-title":"Comparison of the Susceptibility of Plasmodium Knowlesi and Plasmodium Falciparum to Antimalarial Agents","volume":"72","author":"van Schalkwyk","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B59","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijpddr.2021.07.002","article-title":"Ex Vivo Susceptibility to New Antimalarial Agents Differs Among Human-Infecting Plasmodium Species","volume":"17","author":"van Schalkwyk","year":"2021","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.4155\/fmc-2019-0225","article-title":"Recent Advances in Transmission-Blocking Drugs for Malaria Elimination","volume":"11","author":"Wadi","year":"2019","journal-title":"Future Med. Chem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1086\/524889","article-title":"Plasmodium Knowlesi: The Fifth Human Malaria Parasite","volume":"15","author":"White","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B62","unstructured":"Guidelines for Malaria"},{"key":"B63","unstructured":"World Malaria Report2021"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-018-1207-3","article-title":"Association of Mutation in the Plasmodium Falciparum Kelch13 Gene (Pf3D7_1343700) With Parasite Clearance Rates After Artemisinin-Based Treatments \u2013 A WWARN Individual Patient Data Meta-Analysis","volume":"17","year":"2019","journal-title":"BMC Med."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001138","article-title":"Chemical Rescue of Malaria Parasites Lacking an Apicoplast Defines Organelle Function in Blood-Stage Plasmodium Falciparum","volume":"9","author":"Yeh","year":"2011","journal-title":"PloS Biol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.802294\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T05:59:54Z","timestamp":1642139994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.802294\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":65,"alternative-id":["10.3389\/fcimb.2021.802294"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2021.802294","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"article-number":"802294"}}